Participants 119 316 5
In an attempt to investigate the prophylactic effect of a thromboxane A2 (TXA2) synthetase inhibitor on pregnant women with a high risk of preeclampsia, the following clinical study was undertaken.
Participants 325 401 7
Forty pregnant women were randomly allocated to control or treatment groups.
Participants 1343 1384 3
preeclampsia in high-risk pregnant women.
